Health Trials

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

1

Review clinical trials related to Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

This study is conducted to evaluate the efficacy and safety of SHR-8068 combined with Adebrelimab and Apatinib compared with Adebrelimab combined with Apatinib in perioperative treatment of resectable hepatocellular carcinoma with intermediate or high recurrence risk.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.Updated: Jul 2, 2026Locations: 1
Eligibility criteria

Subjects who voluntarily participate in this study and sign the informed consent... [+9]

Known intrahepatic cholangiocarcinoma, sarcomatoid hepatocellular carcinoma, mix... [+9]

Read more